Pyxis Oncology

PYXS51

Penny Stock

$1.81arrow_drop_up2.54%$0.04

Penny Stock

PYXS51

$1.81

arrow_drop_up2.54%$0.04

Penny Stock

Performance History

Key Stats
Open	$1.77
Prev. Close	$1.77
EPS	-1.06
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$108.22M
PE Ratio	-

	LOW	HIGH
Day Range	1.74	1.86
52 Week Range	1.35	6.85

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-1.06

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Pyxis Oncology (PYXS)

Pyxis Oncology, Inc. (PYXS) is a biotechnology company specializing in the development of innovative cancer therapeutics. With a focus on harnessing the power of the immune system to fight cancer, Pyxis Oncology aims to revolutionize the treatment landscape and improve patient outcomes. The company's cutting-edge research and development efforts have garnered attention from investors and industry experts alike, positioning Pyxis Oncology as a promising player in the oncology space.

One of the key indicators of Pyxis Oncology's success is its stock price history. Over the past several years, PYXS stock has experienced significant growth, reflecting the market's confidence in the company's potential. Investors have been drawn to Pyxis Oncology's innovative approach to cancer treatment, recognizing the value of its groundbreaking research and development pipeline. As a result, PYXS stock has consistently outperformed industry averages, making it an attractive investment opportunity for those looking to capitalize on the rapidly evolving field of oncology.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Lara S. Sullivan M.D., MBA
Headquarters: Cambridge
Employees: 72
Exchange: NASDAQ

Keep an eye on Pyxis Oncology

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Pyxis Oncology's (PYXS) price per share?

The current price per share for Pyxis Oncology (PYXS) is $1.81. The stock has seen a price change of $0.04 recently, indicating a 2.54% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Pyxis Oncology (PYXS)?

For Pyxis Oncology (PYXS), the 52-week high is $6.85, which is 277.41% from the current price. The 52-week low is $1.35, the current price is 34.44% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Pyxis Oncology (PYXS) a growth stock?

Pyxis Oncology (PYXS) has shown an average price growth of -3.72% over the past three years. It has received a score of 19 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Pyxis Oncology as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Pyxis Oncology (PYXS) stock price performance year to date (YTD)?

As of the latest data, Pyxis Oncology (PYXS) has a year-to-date price change of -11.89%. Over the past month, the stock has experienced a price change of -52.11%. Over the last three months, the change has been -52.36%. Over the past six months, the figure is -51.47%.

help

Is Pyxis Oncology (PYXS) a profitable company?

Pyxis Oncology (PYXS) has a net income of -$73.79M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -398.68% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$82.2M. Furthermore, the EBITDA is -$63.16M.

help

What is the market capitalization of Pyxis Oncology (PYXS)?

Pyxis Oncology (PYXS) has a market capitalization of $108.23M. The average daily trading volume is 1.81, indicating the stock's liquidity and investor engagement.